glutathione metabolism in cancer progression and treatment resistance Targeting glutamine as a therapeutic strategy for Frontiers | Glutamine's double-edged sword:
Description
Isolated and combined dystonia syndromes - an update on new genes and their phenotypes
This review will discuss aspects related to ADA formation following mAb drug administration
Finding multiple target optimal intervention in disease-related molecular network
L-glutathione with LipoMicel matrix**300 mg
Boon AC, Vos AP, Graus YM, Rimmelzwaan GF, Osterhaus AD
